Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way we treat disease. Orna’s proprietary platform combines novel technology to create oRNAs that drive protein expression with validated and unique delivery solutions. 

MPM Capital

Novartis Institutes for Biomedical Research

Astellas Venture Management

Kite Pharma

Bristol Myers Squibb

F2 Ventures

Taiho Ventures

The Pags Group

Merck

BioImpact

Orna Therapeutics

Harness Therapeutics operates in the biotechnology space with a focus on neurodegenerative diseases. The company develops therapies that control protein synthesis in the body, with the aim of treating neurodegenerative diseases by increasing protein levels in a safe and controlled manner.

Harness Therapeutics

Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way we treat disease. Their technology has applications across multiple disease areas including cancer, regenerative medicine, protein replacement, infectious diseases, and autoimmunity.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Feb 15, 2024 7:23 PM	6c93b928
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Feb 15, 2024 7:23 PM	b6be048d
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Feb 15, 2024 7:23 PM	ffe361ec
translate crunchbase fundingrounds	general
peers	general	Feb 15, 2024 7:23 PM	0e9869d1
news basic	general	Feb 15, 2024 7:23 PM	ee8ed25a
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:ORNATX

Orna Therapeutics